Highline Wealth Partners LLC Ionis Pharmaceuticals Inc Transaction History
Highline Wealth Partners LLC
- $297 Billion
- Q1 2025
A detailed history of Highline Wealth Partners LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Highline Wealth Partners LLC holds 38 shares of IONS stock, worth $1,166. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38Holding current value
$1,166% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IONS
# of Institutions
401Shares Held
132MCall Options Held
829KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$506 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$435 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$352 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$317 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$242 Million5.48% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.36B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...